UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

PLoS medicine, 2012-05, Vol.9 (5), p.e1001216-e1001216

2012

Volltextzugriff (PDF)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

JNCI : Journal of the National Cancer Institute, 2018-08, Vol.110 (8), p.803-811

2018

Volltextzugriff (PDF)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

BMC medicine, 2012-05, Vol.10 (1), p.51-51, Article 51

2012

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Volltextzugriff (PDF)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

JNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.808-819

2021

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Journal of clinical oncology, 2018-07, Vol.36 (20), p.2105-2122

2018

Volltextzugriff (PDF)

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting

Journal of clinical oncology, 2012-12, Vol.30 (34), p.4223-4232

2012

Volltextzugriff (PDF)

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Journal of translational medicine, 2021-06, Vol.19 (1), p.1-269, Article 269

2021

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Archives of pathology & laboratory medicine (1976), 2018-11, Vol.142 (11), p.1364-1382

2018

Volltextzugriff (PDF)

Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue

PloS one, 2015-07, Vol.10 (7), p.e0127353-e0127353

2015

Volltextzugriff (PDF)

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3997-4013

2013

Volltextzugriff (PDF)

Metrology Standards for Quantitative Imaging Biomarkers

Radiology, 2015-12, Vol.277 (3), p.813-825

2015

Volltextzugriff (PDF)

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3883-3894

2020

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update

Journal of clinical oncology, 2023-08, Vol.41 (22), p.3867-3872

2023

Volltextzugriff (PDF)

REMARK guidelines for tumour biomarker study reporting: a remarkable history

British journal of cancer, 2023-02, Vol.128 (3), p.443-445

2023

Volltextzugriff (PDF)

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1134-1150

2016

Volltextzugriff (PDF)

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2121-2127

2011

Volltextzugriff (PDF)

Randomized Clinical Trials With Biomarkers: Design Issues

JNCI : Journal of the National Cancer Institute, 2010-02, Vol.102 (3), p.152-160

2010

Volltextzugriff (PDF)

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

Archives of pathology & laboratory medicine (1976), 2014-02, Vol.138 (2), p.241-256

2014

Volltextzugriff (PDF)

Criteria for the translation of radiomics into clinically useful tests

Nature reviews. Clinical oncology, 2023-02, Vol.20 (2), p.69-82

2023

Volltextzugriff (PDF)

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Journal of clinical oncology, 2020-01, Vol.38 (3), p.214-222

2020

Volltextzugriff (PDF)

Sample size methods for evaluation of predictive biomarkers

Statistics in medicine, 2022-07, Vol.41 (16), p.3199-3210

2022

Volltextzugriff (PDF)

Reporting recommendations for tumor marker prognostic studies

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9067-9072

2005

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Englisch
(325)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Metrology Standards for Quantitative Imaging Biomarkers

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update

REMARK guidelines for tumour biomarker study reporting: a remarkable history

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Randomized Clinical Trials With Biomarkers: Design Issues

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

Criteria for the translation of radiomics into clinically useful tests

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

Sample size methods for evaluation of predictive biomarkers

Reporting recommendations for tumor marker prognostic studies

Suchergebnisse filtern